BOOKMARK
  • Korean|
  • Chinese|
  • Japanese|
  • Vietnamese
본문내용 바로가기

Aju Business Daily

SEARCH
  • ECONOMY
  • ENTERTAINMENT
  • IT
  • South Korea
  • North Korea
  • WORLD
  • SPORTS
  • LIFESTYLE
  • AUTO MOTIVE
  • OPINION
  • PEOPLE
  • MILITARY
Home > Health > article

Turkish company Ilko joins Genexine's COVID-19 vaccine development

Lim Chang-won Reporter(cwlim34@ajunews.com) | Posted : July 1, 2020, 13:18 | Updated : July 1, 2020, 13:18
  • 트위터
  • 페이스북
  • 웨이보

[Courtesy of Genexine]


SEOUL -- Ilko Pharmaceuticals, a pharmaceutical company in Turkey, will work with Genexine, a clinical-stage biotechnology company in South Korea, for the development of GX-19, a DNA vaccine material for COVID-19 that has secured government approval to go ahead with clinical trials.

Genexine said it has signed a memorandum of understanding with its Turkish partner, Ilko Pharmaceuticals, on cooperation in global clinical trials of GX-19 and the establishment of overseas licensing and supply chain. The two companies established a joint venture company in 2013 to develop and commercialize new bio-drugs overseas.

Genexine has been involved in a state-commissioned research consortium that also groups the state-run Korea Advanced Institute of Science & Technology, Pohang University of Science and Technology and the International Vaccine Institute. The consortium started the first testing of a vaccine candidate on monkeys in March and confirmed the generation of antibodies that can neutralize a novel coronavirus.

Genexine partnered with PT Kalbe Farma, a pharmaceutical, healthcare and nutrition company in Indonesia, in May for joint vaccine research, followed by a similar deal with the National Vaccine Institute, a Thai public autonomous authority that coordinates vaccine affairs with domestic and international stakeholders.

  • Lim Chang-won Reporter
  • email : cwlim34@ajunews.com
© Aju Business Daily & www.ajunews.com Copyright: All materials on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the authorization from the Aju News Corporation.
  • twitter
  • facebook
  • weibo
  • link copy
  • LIST
  • TOP

Related news

  • .Genexines DNA vaccine candidate selected to get quick state support .
    Genexine's DNA vaccine candidate selected to get quick state…
  • .Genexine works with domestic partners to use cloned pigs for xenotransplantation.
    Genexine works with domestic partners to use cloned pigs for…
  • .Hyundai department store group expands business scope into beauty and healthcare.
    Hyundai department store group expands business scope into b…
  • .Thai vaccine institute joins Genexines COVID-19 vaccine development.
    Thai vaccine institute joins Genexine's COVID-19 vaccine dev…

Real Time Photo News

  • .S. Korea to build state-run K-pop concert hall for unaffordable online performances .

    S. Korea to build state-run K-pop concert hall for unaffordable online performances

  • .BLACKPINK member Rosé to release solo album in March.

    BLACKPINK member Rosé to release solo album in March

  • .BTS agency posts record earnings in 2020 on brisk online activities and album sales .

    BTS agency posts record earnings in 2020 on brisk online activities and album sales

  • .[FOCUS] BTS agency leagues with Universal Music to launch new K-pop band in US music scene.

    [FOCUS] BTS agency leagues with Universal Music to launch new K-pop band in US music scene

  • .CJ ENM aims to become major visual content producer thru partnership with Epic Games .

    CJ ENM aims to become major visual content producer thru partnership with Epic Games

Latest News

more+

  • S. Korea to build state-run K-pop concert hall for unaffordable online performances
  • Busan to set up barrier-free public transportation environments for disabled
  • Hyundai auto group forges hydrogen alliance with SK Group
  • Scuba diving in Cebu cited as most viewed content in LG Uplus VR platform
  • SKT uses VR platform to hold non-face-to-face entrance ceremony for university freshmen
Aju Business Daily
  • ABOUT US
  • CONTACT US
  • PRIVACY STATEMENT
  • Copyright Policy

Address : Aju News Corporation LEEMA Building, 11th floor, 42, Jong-ro 1-gil, Jongno-gu, Seoul.    Mail : swatchsjp@ajunews.com

Copyright ⓒ 2016 By Ajunews Corporation, All Rights Reserved.

Mobile view